Skip to main content
Filters

    Results for Chemicals & Small Molecules ( 97866 )

      • Ref: T77014
        Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg
        From: €339.00

        Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia. Frovocimab is used to study hypercholesterolemia.

        Product detail
      • Ref: T77061
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €192.00

        Letolizumab (BMS-986004) is a dimeric antibody targeting CD40L for the expression of mutant IgG1 that lacks effector functions including Fc binding and complement binding.1 Letolizumab does not induce platelet activation in vitro and does not affect coagulation factors or platelet counts/function after repeated dosing in non-human primates.

        Product detail
      • Ref: T77066
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €333.00

        Lilotomab (HH1) is a murine anti-CD37 antibody with anti-tumor activity. It can be used as a synthetic anti-CD37 antibody-radionuclide coupling (177Lu-lilotomab satetraxetan).

        Product detail
      • Ref: T77071
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €224.00

        Lonigutamab (hz208F2-4) is a humanized monoclonal antibody targeting the insulin-like growth factor-1 receptor (IGF-1R) for the study of thyroid eye disease.

        Product detail
      • Ref: T77083
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €224.00

        Melrilimab (GSK 3772847) is an IgG antibody targeting IL-33R with high affinity for IL1RL1/ST2/DER4/FIT-1 and can be used in asthma research.

        Product detail
      • Ref: T77084
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €224.00

        Mezagitamab (TAK-079) is a fully humanized IgG1λ monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells), which depletes CD38-expressing tumor cells through antibody- and complement-dependent cytotoxicity Mezagitamab may be used in the study of recurrent/refractory multiple myeloma (RRMM), which is the most common form of cancer. multiple myeloma (RRMM) and primary thrombocytopenic purpura (ITP).

        Product detail
      • Ref: T77102
        Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg
        From: €299.00

        Nofazinlimab (CS1003) is a human anti-PD-1 IgG4 monoclonal antibody used to study unresectable hepatocellular carcinoma (uHCC) and metastatic colorectal cancer.

        Product detail
      • Ref: T77103
        Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg
        From: €224.00

        Nurulimab (BCD-145) is an anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) human monoclonal antibody with anti-cancer activity for the study of skin and musculoskeletal diseases.

        Product detail
      • Ref: T77116
        Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg
        From: €339.00

        Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.

        Product detail